COUGAR BIOTECHNOLOGY CGRB $ 19.55 Change: +0.57 +2.92% | Volume: 62,862
Sponsored by Click here!

COUGAR BIOTECH - Fundamental Profile

Company Information

Ticker Symbol: CGRB
Exchange: NASD
Contact Info: 10990 Wilshire Boulevard Los Angeles CA 90024 310-943-8040
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Cougar Biotechnology, Inc. is a Los Angeles-based biotechnology company established to in-license and develop clinical stage drugs, with a specific focus on the field of oncology. Cougar Biotechnology is a publicly held biotechnology company established to in-license and develop early clinical stage drugs, with a specific focus on the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research.

Share Information

Shares Outstanding: 20,570 (000) Market Value: 360,950 ($000)
Percentage of Inst.Shareholders: 69.96% Number of Inst.Shareholders: 9.90%
Last Quarter Sales: 0.00 ($Mil.) Last Quarter Net Income: -15.58 ($Mil.)
Last Quarter EPS: -0.76 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -1.50
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +12.60 58.23
GILEAD SCIENCES -1.00 46.92
CELGENE CP -10.00 58.86
BIOGEN IDEC INC -31.90 43.52
AMYLIN PHARMA I -85.70 6.41